Literature DB >> 8396712

High affinity amylin binding sites in rat brain.

K Beaumont1, M A Kenney, A A Young, T J Rink.   

Abstract

Amylin, a 37-amino acid peptide structurally related to calcitonin gene-related peptide, is synthesized in and released along with insulin from pancreatic beta-cells. Amylin is proposed to act as an endocrine partner to insulin, in part through actions upon skeletal muscle that promote cycling of gluconeogenic precursors to liver. We report here that binding sites with high affinity (Kd = 27 pm) for radioiodinated rat amylin are present in the nucleus accumbens region of rat brain. Competition experiments show that sites measured in nucleus accumbens membranes have high affinity for rat amylin, lower affinity for rat calcitonin gene-related peptides, and very low affinity for rat calcitonin. In contrast to rat calcitonin, salmon calcitonin has a high affinity for these sites, indicating that it shares critical binding determinants with amylin. We further tested whether salmon calcitonin shares with amylin the ability to regulate glycogen metabolism in rat skeletal muscle. Salmon calcitonin potently inhibits insulin-stimulated glucose incorporation into rat soleus muscle glycogen, suggesting that rat skeletal muscle may also contain receptor populations that have high affinity for both amylin and salmon calcitonin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396712

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.

Authors:  Nicholas T Bello; Matthew H Kemm; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

3.  Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.

Authors:  Sarah K Baisley; Brian A Baldo
Journal:  Neuropsychopharmacology       Date:  2014-06-24       Impact factor: 7.853

Review 4.  Pancreatic signals controlling food intake; insulin, glucagon and amylin.

Authors:  Stephen C Woods; Thomas A Lutz; Nori Geary; Wolfgang Langhans
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  Circadian anorectic effects of peripherally administered amylin in rats.

Authors:  T A Lutz; E Del Prete; M M Szabady; E Scharrer
Journal:  Z Ernahrungswiss       Date:  1995-09

Review 6.  GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Authors:  Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

8.  Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.

Authors:  R A Pittner; D Wolfe-Lopez; A A Young; K Beaumont
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.

Authors:  Elizabeth G Mietlicki-Baase; Laura E Rupprecht; Diana R Olivos; Derek J Zimmer; Mark D Alter; R Christopher Pierce; Heath D Schmidt; Matthew R Hayes
Journal:  Neuropsychopharmacology       Date:  2013-03-08       Impact factor: 7.853

10.  Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.

Authors:  Gina Ryan; Tim A Briscoe; Lynette Jobe
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.